Source: International Congress 2018 – Lung cancer: personalised medicine
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Walter (Neuherberg, Germany), R. Holle (Neuherberg, Germany), A. Tufman (München, Germany), L. Schwarzkopf (Neuherberg, Germany). Changes in targeted therapy and costs in NSCLC between 2009 and 2013. 2216

Member's Comments

No comment yet.

Related content which might interest you: Changes in the patterns of care for lung cancer from 1996 to 2001 in an Australian region Source: Eur Respir J 2006; 28: Suppl. 50, 832s Year: 2006 Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Lung cancer in Berlin – Therapeutic concepts and their impact on survival in patients with NSCLC stage II/III from 2000 to 2008 Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study Source: Eur Respir J 2015; 46: 1131-1139 Year: 2015 Comparative analysis of lung cancer presentation between 1990 and 2003 Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 Trends among patients with long-term oxygen therapy in Sweden 1987-2000 Source: Annual Congress 2003 - Intervention strategies in chronic respiratory failure Year: 2003 Consideration about the results of antituberculous chemotherapy in Romania 2005-2006 Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Stage, therapy and surviving of small cell lung cancer: analysis of a nonselected patient collective 1993-1997 Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 Smoking status in Danish lung cancer patients compared to the general population, 2005 - 2013 Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013 Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Study of patients with lung cancer treated surgically in Albania during the period 2000-2003 Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Treatment outcome of XDR-TB patients in Iran during 2003-2006 Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Sleeve-pneumonectomy for lung cancer – survival and complications (update 2005) Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005 Relapse after radical surgery for non-small cell lung cancer 2005-2009 – A retrospective quality management analysis Source: Annual Congress 2011 - How to improve lung cancer care Year: 2011 Improvement of the survival of lung cancer in a French monocentric cohort between 1990 and 2010 Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 EGFR mutation diagnostic program for NSCLC patients in Poland between 2011-2014 Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013 Source: International Congress 2015 – Quality management in lung cancer Year: 2015 A considerable reduction of the diagnostic delay from 2000 to 2008 has at most contributed to a modest improvement of survival in Danish lung cancer patients Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009